EUVIMEDEUVIMED entdecken
Open Access

Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk

Alaina M Bever iD, Dong Hang, Dong Hoon Lee iD, Fred K Tabung iD, Tomotaka Ugai, Shuji Ogino, Jeffrey A Meyerhardt, Andrew T Chan iD, A Heather Eliassen, Liming Liang, Meir J Stampfer, Mingyang Song iD

JNCI: Journal of the National Cancer Institute · 2024

DOI: 10.1093/jnci/djae047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2024. Verfasst von Alaina M Bever und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Inflammation, Metabolomics, Body Mass Index. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Prevent Cancer Foundation, American Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation and metabolic dysregulation are associated with increased risk of colorectal cancer (CRC); the underlying mechanisms are not fully understood. We characterized metabolomic signatures of inflammation and metabolic dysregulation and evaluated the association of the signatures and individual metabolites with CRC risk.

Methods

Among 684 incident CRC cases and 684 age-matched controls in the Nurses’ Health Study (n = 818 women) and Health Professionals Follow-up Study (n = 550 men), we applied reduced rank and elastic net regression to 277 metabolites for markers of inflammation (C-reactive protein, interleukin 6, tumor necrosis factor receptor superfamily member 1B, and growth differentiation factor 15) or metabolic dysregulation (body mass index, waist circumference, C-peptide, and adiponectin) to derive metabolomic signatures. We evaluated the association of the signatures and individual metabolites with CRC using multivariable conditional logistic regression. All statistical tests were 2-sided.

Results

We derived a signature of 100 metabolites that explained 24% of variation in markers of inflammation and a signature of 73 metabolites that explained 27% of variation in markers of metabolic dysregulation. Among men, both signatures were associated with CRC (odds ratio [OR] = 1.34, 95% confidence interval [CI] = 1.07 to 1.68 per 1-standard deviation increase, inflammation; OR = 1.25, 95% CI = 1.00 to 1.55 metabolic dysregulation); neither signature was associated with CRC in women. A total of 11 metabolites were individually associated with CRC and biomarkers of inflammation or metabolic dysregulation among either men or women.

Conclusion

We derived metabolomic signatures and identified individual metabolites associated with inflammation, metabolic dysregulation, and CRC, highlighting several metabolites as promising candidates involved in the inflammatory and metabolic dysregulation pathways for CRC incidence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsInflammationMetabolomicsBody Mass IndexC-Reactive ProteinHumansMaleFemaleMiddle AgedCase-Control StudiesAgedRisk FactorsAdultInterleukin-6AdiponectinWaist CircumferenceC-PeptideMetabolomeFollow-Up StudiesBiomarkers, TumorProspective StudiesLogistic Models

Substanzen

C-Reactive ProteinInterleukin-6AdiponectinC-PeptideBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, MA, USA.
  • Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical Un…
  • Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Department of Sport Industry Studies, Yonsei University, Seoul, Republic of Korea.
  • The Ohio State University College of Medicine and Comprehensive Cancer Center, Columbus, OH, USA.

ORCID-Profile: Alaina M Bever, Dong Hoon Lee, Fred K Tabung, Andrew T Chan, Mingyang Song

Förderung

  • NCI NIH HHS
  • Prevent Cancer Foundation
  • American Cancer Society
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health

Zitieren

APA

Bever, A. M., Hang, D., Lee, D. H., Tabung, F. K., Ugai, T., Ogino, S., Meyerhardt, J. A., Chan, A. T., Eliassen, A. H., Liang, L., Stampfer, M. J., & Song, M. (2024). Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djae047

Vancouver

Bever AM, Hang D, Lee DH, Tabung FK, Ugai T, Ogino S, et al. Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk. JNCI: Journal of the National Cancer Institute. 2024. doi:10.1093/jnci/djae047

BibTeX
@article{Bever2024,
  author = {Bever, Alaina M and Hang, Dong and Lee, Dong Hoon and Tabung, Fred K and Ugai, Tomotaka and Ogino, Shuji and Meyerhardt, Jeffrey A and Chan, Andrew T and Eliassen, A Heather and Liang, Liming and Stampfer, Meir J and Song, Mingyang},
  title = {Metabolomic signatures of inflammation and metabolic dysregulation in relation to colorectal cancer risk},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2024},
  doi = {10.1093/jnci/djae047}
}
Kostenlos starten →